This is a non-core endpoint: only basic statistics are computed.
Erythema annulare centrifugum
DOID EFO MESH SNOMED Endpoint Browser
L12_ERYTH_ANNULCENTRIFUG
erythema infectiosum: usually a benign childhood condition characterized by a classic slapped-cheek appearance (see the image below) and lacy exanthem.It results from infection with human parvovirus (PV) B19, an erythrovirus.
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
Hospital Discharge: ICD-10
L53.1
Hospital discharge: ICD-9
6958B
Hospital discharge: ICD-8
69591
Cause of death: ICD-10
L53.1
Cause of death: ICD-9
6958B
Cause of death: ICD-8
69591
2 out of 7 registries used, show all original rules.
48
Check minimum number of events None
48
Include endpoints None
48
Remove individuals based on genotype QC
46
L12_ERYTH_ANNULCENTRIFUG
Control definitions
Control exclude
L12_URTICARIAERYTHEMA
Extra metadata
Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
L53
Name in latin
Erythema anulare centrifugum
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Erythema annulare centrifugum
based on the number of shared cases.
Broader endpoints:
- Other erythematous conditions
- Urticaria and erythema
- Diseases of the skin and subcutaneous tissue
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Narrower endpoints:
None
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 46 | 30 | 16 |
| Unadjusted prevalence (%) | 0.01 | 0.01 | 0.01 |
| Mean age at first event (years) | 56.14 | 53.96 | 60.24 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: L12_ERYTH_ANNULCENTRIFUG – Erythema annulare centrifugum
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Erythema annulare centrifugum
↥Endpoint not on priority list, no data to show.